Nucana Plc logo

Nucana Plc Share Price Today

(NASDAQ: NCNA)

Nucana Plc share price is $0.91 & ₹79.14 as on 6 Mar 2025, 2.30 'hrs' IST

$0.91

Market is closed - opens 8 PM, 06 Mar 2025

View live Nucana Plc share price in Dollar and Rupees. Guide to invest in Nucana Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nucana Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Nucana Plc share price movements

  • Today's Low: $0.89
    Today's High: $0.94

    Day's Volatility :5.44%

  • 52 Weeks Low: $0.85
    52 Weeks High: $19.41

    52 Weeks Volatility :95.62%

Nucana Plc (NCNA) Returns

PeriodNucana PlcSector (Health Care)Index (Russel 2000)
3 Months
-25.41%
3.7%
0.0%
6 Months
-66.67%
-2.8%
0.0%
1 Year
-88.71%
2.5%
0.0%
3 Years
-95.49%
12.9%
-11.6%

Nucana Plc (NCNA) Key Statistics

in dollars & INR

Previous Close
$0.9116
Open
$0.9047
Today's High
$0.9407
Today's Low
$0.889499
Market Capitalization
$3.6M
Today's Volume
$9.9K
52 Week High
$19.41
52 Week Low
$0.85
Revenue TTM
$0.0
EBITDA
$-29.5M
Earnings Per Share (EPS)
$-14.81
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-199.06%

How to invest in Nucana Plc Stock (NCNA) from India?

It is very easy for Indian residents to invest directly in Nucana Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nucana Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nucana Plc or NCNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nucana Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nucana Plc shares which would translate to 0.956 fractional shares of Nucana Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nucana Plc, in just a few clicks!

Returns in Nucana Plc (NCNA) for Indian investors in Rupees

The Nucana Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nucana Plc investment value today

Current value as on today

₹16,239

Returns

₹83,761

(-83.76%)

Returns from Nucana Plc Stock

₹88,710 (-88.71%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Nucana Plc (NCNA)

109%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nucana Plc Stock from India on INDmoney has increased by 109% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Nucana Plc

  • The Carlyle Group Inc

    3.40%

  • Susquehanna International Group, LLP

    1.19%

  • Schonfeld Strategic Advisors LLC

    1.15%

  • Virtu Financial LLC

    1.03%

  • Baillie Gifford & Co Limited.

    0.94%

  • Citadel Advisors Llc

    0.64%

Analyst Recommendation on Nucana Plc

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Nucana Plc(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Nucana Plc Stock (NCNA)

What analysts predicted

Upside of 6987.91%

Target:

$64.50

Current:

$0.91

Insights on Nucana Plc Stock (Ticker Symbol: NCNA)

  • Price Movement

    In the last 6 months, NCNA stock has moved down by -67.8%
  • NCNA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 155.2%
  • NCNA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 147.8%

Nucana Plc Technicals Summary

Sell

Neutral

Buy

Nucana Plc is currently in a neutral trading position according to technical analysis indicators.

Nucana Plc (NCNA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nucana Plc logo
-11.65%
-66.67%
-88.71%
-95.49%
-99.45%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nucana Plc logo
NA
NA
NA
-15.75
-1.99
-0.7
NA
1.11
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nucana Plc logo
Buy
$3.6M
-99.45%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Nucana Plc

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer, Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer, and Phase 1b/2 modular clinical trial for patients with advanced solid tumors and lung cancer. It is also developing NUC-7738, a ProTide transformation of 3'-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.
Organization
Nucana Plc
Employees
25
CEO
Mr. Hugh Stephen Griffith
Industry
Health Technology

Management People of Nucana Plc

NameTitle
Mr. Hugh Stephen Griffith
Founder, CEO & Executive Director
Mr. David Harrison
Head of Translational Medicine
Dr. Jeffrey D. Bloss F.A.C.O.G., M.D.
Chief Medical Officer
Ms. Theresa Bruce
Senior Vice President of Clinical Operations
Ms. Elisabeth Oelmann
Senior Vice President of Medical & Clinical Development
Mr. John-Paul Gallivan
Senior VP of Strategy & Lifecycle Management
Mr. Gordon Kennovin
Senior VP of CMC & Development
Dr. Stuart Grant
Senior Vice President of Regulatory Affairs
Martin Quinn
Company Secretary

Important FAQs about investing in NCNA Stock from India :

What is Nucana Plc share price today?

Nucana Plc share price today stands at $0.91, Open: $0.90 ; Previous Close: $0.91 ; High: $0.94 ; Low: $0.89 ; 52 Week High: $19.41 ; 52 Week Low: $0.85.

The stock opens at $0.90, after a previous close of $0.91. The stock reached a daily high of $0.94 and a low of $0.89, with a 52-week high of $19.41 and a 52-week low of $0.85.

Can Indians buy Nucana Plc shares?

Yes, Indians can invest in the Nucana Plc (NCNA) from India.

With INDmoney, you can buy Nucana Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nucana Plc at zero transaction cost.

How can I buy Nucana Plc shares from India?

It is very easy to buy Nucana Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nucana Plc (NCNA) be purchased?

Yes, you can buy fractional shares of Nucana Plc with INDmoney app.

What are the documents required to start investing in Nucana Plc stocks?

To start investing in Nucana Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nucana Plc Stock (NCNA)?

Today’s highest price of Nucana Plc (NCNA) is $0.94.

Today’s lowest price of Nucana Plc (NCNA) is $0.89.

What is today's market capitalisation of Nucana Plc?

Today's market capitalisation of Nucana Plc NCNA is 3.6M

What is the 52 Week High and Low Range of Nucana Plc Stock (NCNA)?

  • 52 Week High

    $19.41

  • 52 Week Low

    $0.85

What are the historical returns of Nucana Plc (NCNA)?

  • 1 Month Returns

    -11.65%

  • 3 Months Returns

    -66.67%

  • 1 Year Returns

    -88.71%

  • 5 Years Returns

    -99.45%

Who is the Chief Executive Officer (CEO) of Nucana Plc ?

Mr. Hugh Stephen Griffith is the current Chief Executive Officer (CEO) of Nucana Plc.